{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T13:52:06Z","timestamp":1781531526213,"version":"3.54.5"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Genetics and Metabolism Reports"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.ymgmr.2023.100997","type":"journal-article","created":{"date-parts":[[2023,8,7]],"date-time":"2023-08-07T18:36:11Z","timestamp":1691433371000},"page":"100997","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["GAA variants associated with reduced enzymatic activity but lack of Pompe-related symptoms, incidentally identified by exome sequencing"],"prefix":"10.1016","volume":"36","author":[{"given":"Anna","family":"Malekkou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Athina","family":"Theodosiou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelos","family":"Alexandrou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ioannis","family":"Papaevripidou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolina","family":"Sismani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edwin H.","family":"Jacobs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George J.G.","family":"Ruijter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Violetta","family":"Anastasiadou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofia","family":"Ourani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilia","family":"Athanasiou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthi","family":"Drousiotou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga","family":"Grafakou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petros P.","family":"Petrou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymgmr.2023.100997_bb0005","doi-asserted-by":"crossref","DOI":"10.3390\/biom10091339","article-title":"Pompe disease: new developments in an old lysosomal storage disorder","volume":"10","author":"Meena","year":"2020","journal-title":"Biomolecules"},{"key":"10.1016\/j.ymgmr.2023.100997_bb0010","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1002\/humu.24148","article-title":"Update of the Pompe variant database for the prediction of clinical phenotypes: novel disease-associated variants, common sequence variants, and results from newborn screening","volume":"42","author":"de Faria","year":"2021","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.ymgmr.2023.100997_bb0015","doi-asserted-by":"crossref","first-page":"177","DOI":"10.3389\/fnagi.2014.00177","article-title":"Pompe disease: from pathophysiology to therapy and back again","volume":"6","author":"Lim","year":"2014","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.ymgmr.2023.100997_bb0020","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.2147\/TCRM.S334232","article-title":"Therapeutic options for the Management of Pompe Disease: current challenges and clinical evidence in therapeutics and clinical risk management","volume":"18","author":"Bolano-Diaz","year":"2022","journal-title":"Ther. Clin. Risk Manag."},{"key":"10.1016\/j.ymgmr.2023.100997_bb0025","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1111\/ene.13285","article-title":"European Pompe consortium, European consensus for starting and stopping enzyme replacement therapy in adult patients with Pompe disease: a 10-year experience","volume":"24","author":"van der Ploeg","year":"2017","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.ymgmr.2023.100997_bb0030","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1007\/s10545-009-1082-3","article-title":"Enzyme analysis for Pompe disease in leukocytes; superior results with natural substrate compared with artificial substrates","volume":"32","author":"van Diggelen","year":"2009","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgmr.2023.100997_bb0035","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1373\/clinchem.2011.178319","article-title":"Rapid ultraperformance liquid chromatography-tandem mass spectrometry assay for a characteristic glycogen-derived tetrasaccharide in Pompe disease and other glycogen storage diseases","volume":"58","author":"Sluiter","year":"2012","journal-title":"Clin. Chem."},{"key":"10.1016\/j.ymgmr.2023.100997_bb0040","doi-asserted-by":"crossref","first-page":"E13","DOI":"10.1002\/humu.20745","article-title":"GAA database consortium, update of the Pompe disease mutation database with 107 sequence variants and a format for severity rating","volume":"29","author":"Kroos","year":"2008","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.ymgmr.2023.100997_bb0045","first-page":"141","article-title":"Clinical and GAA gene mutation analysis in mainland Chinese patients with late-onset Pompe disease: identifying c.2238G > C as the most common mutation, BMC","volume":"15","author":"Liu","year":"2014","journal-title":"Med. Genet."},{"key":"10.1016\/j.ymgmr.2023.100997_bb0050","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.ymgme.2011.06.010","article-title":"Rapid progressive course of later-onset Pompe disease in Chinese patients","volume":"104","author":"Yang","year":"2011","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgmr.2023.100997_bb0055","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.ymgme.2009.12.014","article-title":"Genetic heterozygosity and pseudodeficiency in the Pompe disease newborn screening pilot program","volume":"99","author":"Labrousse","year":"2010","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgmr.2023.100997_bb0060","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.jpeds.2005.11.033","article-title":"Infantile-onset Pompe disease natural history study, a retrospective, multinational, multicenter study on the natural history of infantile-onset Pompe disease","volume":"148","author":"Kishnani","year":"2006","journal-title":"J. Pediatr."},{"key":"10.1016\/j.ymgmr.2023.100997_bb0065","first-page":"39","article-title":"Identification and functional characterization of GAA mutations in Colombian patients affected by Pompe disease","volume":"7","author":"Nino","year":"2013","journal-title":"JIMD Rep."},{"key":"10.1016\/j.ymgmr.2023.100997_bb0070","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1002\/humu.23158","article-title":"PERCH: a unified framework for disease gene prioritization","volume":"38","author":"Feng","year":"2017","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.ymgmr.2023.100997_bb0075","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1186\/s13073-022-01120-z","article-title":"MetaRNN: differentiating rare pathogenic and rare benign missense SNVs and InDels using deep learning","volume":"14","author":"Li","year":"2022","journal-title":"Genome Med."},{"key":"10.1016\/j.ymgmr.2023.100997_bb0080","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/j.ajhg.2016.08.016","article-title":"REVEL: an ensemble method for predicting the pathogenicity of rare missense variants","volume":"99","author":"Ioannidis","year":"2016","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.ymgmr.2023.100997_bb0085","first-page":"65","article-title":"Outcome of patients with classical infantile pompe disease receiving enzyme replacement therapy in Germany","volume":"20","author":"Hahn","year":"2015","journal-title":"JIMD Rep."},{"key":"10.1016\/j.ymgmr.2023.100997_bb0090","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1373\/clinchem.2016.259036","article-title":"Liquid chromatography-tandem mass spectrometry assay of leukocyte acid alpha-glucosidase for post-newborn screening evaluation of Pompe disease","volume":"63","author":"Lin","year":"2017","journal-title":"Clin. Chem."},{"key":"10.1016\/j.ymgmr.2023.100997_bb0095","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1002\/mgg3.480","article-title":"Contribution of next generation sequencing in pediatric practice in Lebanon. A study on 213 cases","volume":"6","author":"Nair","year":"2018","journal-title":"Mol. Genet. Genomic Med."},{"key":"10.1016\/j.ymgmr.2023.100997_bb0100","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3390\/ijns6010009","article-title":"The first year experience of newborn screening for Pompe disease in California","volume":"6","author":"Tang","year":"2020","journal-title":"Int. J. Neonatal. Screen"},{"key":"10.1016\/j.ymgmr.2023.100997_bb0105","doi-asserted-by":"crossref","DOI":"10.3390\/ijns6040089","article-title":"Newborn screening for Pompe disease: Pennsylvania experience","volume":"6","author":"Ficicioglu","year":"2020","journal-title":"Int. J. Neonatal. Screen"},{"key":"10.1016\/j.ymgmr.2023.100997_bb0110","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1002\/humu.22108","article-title":"GAA database consortium, update of the pompe disease mutation database with 60 novel GAA sequence variants and additional studies on the functional effect of 34 previously reported variants","volume":"33","author":"Kroos","year":"2012","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.ymgmr.2023.100997_bb0115","first-page":"440","article-title":"Identification of the base-pair substitution responsible for a human acid alpha glucosidase allele with lower \"affinity\" for glycogen (GAA 2) and transient gene expression in deficient cells","volume":"47","author":"Martiniuk","year":"1990","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.ymgmr.2023.100997_bb0120","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1007\/s10038-007-0191-9","article-title":"Structural and biochemical studies on Pompe disease and a \"pseudodeficiency of acid alpha-glucosidase\"","volume":"52","author":"Tajima","year":"2007","journal-title":"J. Hum. Genet."},{"key":"10.1016\/j.ymgmr.2023.100997_bb0125","article-title":"French Pompe study, urine glucose tetrasaccharide: a good biomarker for glycogenoses type II and III? A study of the French cohort","volume":"23","author":"Piraud","year":"2020","journal-title":"Mol. Genet. Metab. Rep."},{"key":"10.1016\/j.ymgmr.2023.100997_bb0130","doi-asserted-by":"crossref","first-page":"286","DOI":"10.21037\/atm.2019.06.60","article-title":"Diagnostic tools in late onset Pompe disease (LOPD)","volume":"7","author":"Musumeci","year":"2019","journal-title":"Ann. Transl. Med."},{"key":"10.1016\/j.ymgmr.2023.100997_bb0135","doi-asserted-by":"crossref","DOI":"10.3390\/genes14020362","article-title":"Treatment dilemma in children with late-onset Pompe disease","volume":"14","author":"Faraguna","year":"2023","journal-title":"Genes (Basel)"},{"key":"10.1016\/j.ymgmr.2023.100997_bb0140","article-title":"ACMG secondary findings working group. Electronic address: documents@acmg.net, ACMG SF v3.2 list for reporting of secondary findings in clinical exome and genome sequencing: a policy statement of the American College of Medical Genetics and Genomics (ACMG)","volume":"100866","author":"Miller","year":"2023","journal-title":"Genet. Med."},{"key":"10.1016\/j.ymgmr.2023.100997_bb0145","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1038\/msb.2011.75","article-title":"Fast, scalable generation of high-quality protein multiple sequence alignments using Clustal omega","volume":"7","author":"Sievers","year":"2011","journal-title":"Mol. Syst. Biol."}],"container-title":["Molecular Genetics and Metabolism Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214426923000435?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214426923000435?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T12:54:01Z","timestamp":1762001641000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2214426923000435"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":29,"alternative-id":["S2214426923000435"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgmr.2023.100997","relation":{},"ISSN":["2214-4269"],"issn-type":[{"value":"2214-4269","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"GAA variants associated with reduced enzymatic activity but lack of Pompe-related symptoms, incidentally identified by exome sequencing","name":"articletitle","label":"Article Title"},{"value":"Molecular Genetics and Metabolism Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymgmr.2023.100997","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"100997"}}